期刊文献+

TFPI-2基因表达变化与声门上喉癌侵袭转移及预后的相关性研究 被引量:4

Correlation of TFPI-2 gene expression with invasion, metastasis, and prognosis of supraglottic carcinoma
下载PDF
导出
摘要 目的:探讨TFPI-2基因的表达与声门上喉癌侵袭转移及预后的关系。方法:运用反转录-聚合酶链反应(RT—PCR)及免疫组织化学方法检测TFPI-2在声门上喉癌组织中的表达,分析其与声门上喉癌临床病理特征的关系。结果:TFPI-2在声门上喉癌组织中mRNA和蛋白表达的阳性率明显增加(P〈0.05),TFPI-2 mRNA和蛋白表达随声门上喉癌的浸润深度的增加而降低(P〈0.05),在淋巴结转移组低于非淋巴结转移组(P〈0.05),在临床Ⅲ-Ⅳ期的表达低于临床Ⅰ-Ⅱ期(P〈0.05)。TFPI-2蛋白染色强度随声门上喉癌的侵袭程度增加及淋巴结转移而降低(P〈0.05)。TFPI-2蛋白表达阴性组声门上喉癌患者较阳性组者预后差(P〈0.05)。结论:TFPI-2表达下调可能与声门上喉癌的侵袭转移密切相关,可作为评估声门上喉癌淋巴结转移及预后的指标。 Objective:To investigate the relationship between TFPI-2 gene expression and the invasion, metastasis, and prognosis of supraglottic carcinoma. Methods: Reverse transcriptase polymerase chain reaction and immunohistochemical methods were used to examine the expression of TFPI-2 in supraglottic carcinoma, and the relationship between TFPI-2 expression and the clinicopathological features of supraglottic carcinoma were analyzed. Results : Positive ratio of TFPI-2 expression was significantly increased at protein and mRNA levels in supraglottic carcinoma tissues (P 〈 0.05 ). TFPI-2 mRNA and protein expression were decreased with the increase in the invasive depth of supraglottic carcinoma ( P 〈 0.05 ). TFPI-2 mRNA and protein expression were significantly lower in supraglottic carcinoma tissues with nodal metastasis and at Ⅲ-Ⅳ clinical stage than those without nodal metastasis and at Ⅰ-Ⅱ clinical stage ( P 〈 0.05). The staining intensity of TFPI-2 protein was also decreased with increase in invasive depth and nodal metastasis ( P 〈 0.05). The supraglottic carcinoma patients with negative TFPI-2 protein expression had poor prognosis than those with positive TFPI-2 expression. Conclusion: The downregulation of TFPI-2 has a close relationship with invasion and metastasis of supraglottic carcinoma, and it may serve as a helpful marker in evaluating the metastasis and prognosis of supraglottic carcinoma.
出处 《肿瘤》 CAS CSCD 北大核心 2008年第1期40-43,共4页 Tumor
基金 国家自然科学基金资助项目(编号:30540010) 黑龙江省青年基金资助项目(编号:QC06C054)
关键词 喉肿瘤 组织途径抑制因子2 基因表达 肿瘤转移 预后 Laryngeal neoplasms Tissue factor pathway inhibitor 2 Gene expression Neoplasm metastasis Prognosis
  • 相关文献

参考文献9

  • 1张清华,李少林,彭志平,周祖平,李军,胡宝云,李臣基.PTEN与MMP-9在子宫内膜癌中的表达及临床意义[J].肿瘤,2006,26(5):476-479. 被引量:7
  • 2KONDURI SD, TASIOU A, CHANDRASEKAR N, et al. Role of tissue factor pathway inhibitor-2 ( TFPI-2 ) in amelanotic melanoma ( C-32 ) invasion [ J ]. Clin Exp Metastasis, 2000, 18 ( 4 ) : 303- 308.
  • 3LAKKA SS, KONDURI SD, MOHANAM S, et al. In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2 [ J ]. Clin Exp Metastasis, 2000,18(3) :239-244.
  • 4KONDURI S D, RAO C N, CHANDRASEKAR N, et al. A novel function of tissue factor pathway inhibitor-2 ( TFPI-2 ) in human glioma invasion[ J]. Oncogene,2001,20 (47) :6938-6945.
  • 5仲任,黄瑞滨,宋善俊.组织因子途径抑制物2抑制卵巢癌细胞浸润转移的体外研究[J].中华妇产科杂志,2003,38(10):641-642. 被引量:3
  • 6SUN Y N, XIE M Q, LIU M, et al. Growth suppression of human laryngeal squamous cell carcinoma by adenovirus-mediated tissue factor pathway inhibitor gene 2 [ J ]. Laryngoscope ,2006,116 (4) : 596-601.
  • 7IZUMI H, TAKAHASHI C, OH J, et al. Tissue factor pathway inhibitor-2 suppresses the production of active matrix metalloproteinase-2 and is down-regulated in cells harboring activated ras oncogenes [ J ]. FEBS Lett, 2000,481 ( 1 ) : 31-36.
  • 8ROLLIN J, IOCHMANN S, BLECHET C, et al. Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer[ J ]. Br J Cancer, 2005, 92 (4) :775-783.
  • 9SATO N, PARKER A R, FUKUSHIMA N, et al. Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma[ J ]. Oncogene, 2005,24 ( 5 ) :850-858.

二级参考文献10

  • 1TASHIRO H,BLAZES MS,WU R,et al.Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies[J].Cancer Res,1997,57 (18):3935-3940.
  • 2IURLARO M,LOVERRO G,VACCA A,et al.Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma[J].Eur J Clin Invest,1999,29(9):793-801.
  • 3LESLIE NR,YANG X,DOWNES CP,et al.The regulation of cell migration by PTEN[J].Biochem Soc Trans,2005,33(12):1507-1508.
  • 4STAMBOLIC V,SUZUKI A,POMPA J l,et al.Negative regulation of PKB/AKT dependent cell survival by the tumor suppressor PTEN[J].Cell,1998,95(1):29-39.
  • 5JIN X,COSSETT DR,WANG S,et al.Inhibition of AKT survival pathway by a small molecule inhibitor in human endometrial cancer cells[J].Br J Cancer,2004,91(10):1808-1812.
  • 6TAMURA M,GU J,MATSUMOTO K,et al.Inhibition of cell migration,spreading and focal adhesion by tumor suppressor PTEN[J].Science,1998,280(5369):1614-1617.
  • 7JADHAV U,CHIGURUPATI S,LAKKA SS,et al.Inhibition of matrix metalloproteinase-9 reduces in vitro invasion and angiogenesis in human microvascular endothelial cells[J].Int J Oncol,2004,25(5):1407-1414.
  • 8di CRISTOFANO A,PANDOLFI P P.The multiple role of PTEN in tumor suppression[J].Cell,2000,100(4):387-390.
  • 9Santhi D. Konduri,Anastasia Tasiou,Nirmala Chandrasekar,Garth L. Nicolson,J.S. Rao. Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion[J] 2000,Clinical and Experimental Metastasis(4):303~308
  • 10Sajani S. Lakka,Santhi D. Konduri,Sanjeeva Mohanam,Garth L. Nicolson,Jasti S. Rao. In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2[J] 2000,Clinical and Experimental Metastasis(3):239~244

共引文献8

同被引文献51

  • 1徐勇,刘雪燕,李体远,杜珙.中国人TFPI-2基因的克隆及测序分析[J].国外医学(临床生物化学与检验学分册),2005,26(7):388-389. 被引量:5
  • 2毕晓,徐勇,涂植光.中国人组织因子途径抑制物-2基因的真核表达载体的构建[J].国际检验医学杂志,2007,28(2):106-107. 被引量:5
  • 3徐卫东,赵建国,殷辉,焦钢,王晓燕.原发性骨肉瘤中γ-synuclein的表达[J].第二军医大学学报,2007,28(4):427-429. 被引量:4
  • 4KONDRAGANTI S,GONDI C S,GUIRATI M,et al.Restoration of tissue factor pathway inhibitor inhibits invasion and tumor growth in vitro and in vivo in a malignant meningioma cell line[J].Int J Oncol,2006,29 (1):25-32.
  • 5CHAND H S,DU X,MA D,et al.The effect of human tissue factor pathway inhibitor-2 on the growth and metastasis of fibrosarcoma tumors in athymic mice[J].Blood,2004,103(3):1069-1077.
  • 6NEAUD V,DUPLANTIER J G,MAZZOCCO C,et al.Thrombin up-regulates tissue factor pathway inhibitor-2 synthesis through a cyclooxygenase-2-dependent,epidermal growth factor receptor-independent mechanism[J].J Biol Chem,2004,279(7):5200-5206.
  • 7KONG D,MA D,BAI H,et al.Expression and characterization of the first kunitz domain of human tissue factor pathway inhibitor-2[J].Biochem Biophys Res Commun,2004,324 (4):1179-1185.
  • 8CHAND H S,FOSTER D C,KISIEL W.Structure,function and biology of tissue factor pathway inhibitor-2[J].Thromb Haemost,2005,94(6):1122-1130.
  • 9KONDURI S D,RAO C N,CHANDRASEKAR N,et al.A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion[J].Oncogene,2001,20(47):6938-6945.
  • 10JI H , LIU Y E, JIA T, et al. Identification of a breast cancerspecific gene, BCSG1, by direct differential cDNA sequencing [J]. Cancer Res,1997,57(4) : 759-764.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部